Investigating the role of interleukin-17-producing cells in the pathophysiology of canine immune mediated hemolytic anemia
Canine primary immune-mediated hemolytic anemia (IMHA) is an acute and severe disease of dogs, with a mortality rate ranging up to 70% in some studies. This study is examining a protein called interleukin-17 (IL-17), and the cells that produce this protein. IL-17 is found in increased amounts in people with certain disease processes, and could be involved in canine IMHA.
Due to the need for fresh blood samples for this study, patient enrollment is limited to the Ontario Veterinary College. Participants in the study must be referred to the Ontario Veterinary College Health Sciences Centre by their primary veterinarian for care of newly diagnosed and untreated IMHA.
Owner's Responsibilities (Samples and Information to be collected):
Blood samples will be collected from dogs upon study enrollment. Whenever possible, this blood collection will be timed to occur during the same time that blood is being collected for recommended diagnostic tests.
Name: Dr. Shauna Blois
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.